Solon Eiendom ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Solon Eiendom ASA with three other
pharmaceutical manufacturers in Europe:
sales of 333.07 million Romanian Leu [US$78.41 million]
(705.90 million Swedish Kronor [US$80.01 million]
of which 68%
was Zubsolv), and
Quantum Pharma PLC
based in the United Kingdom
(£69.99 million [US$86.51 million]
of which 85%
Sales increased substantially in 2016:
During the year ended December of 2016, sales at
Solon Eiendom ASA were NOK 691.50 million (US$81.58 million).
increase of 813,425.9%
versus 2015, when the company's sales were NOK 85,000.00 .